NYSE - Delayed Quote USD

U.S. Physical Therapy, Inc. (USPH)

103.39 +3.46 (+3.46%)
At close: April 23 at 4:00 PM EDT
103.39 0.00 (0.00%)
After hours: April 23 at 6:00 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 6666
Avg. Estimate 0.560.82.773.09
Low Estimate 0.460.662.572.92
High Estimate 0.670.933.193.35
Year Ago EPS 0.590.762.562.77

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 6666
Avg. Estimate 153.37M160.64M637.06M669.4M
Low Estimate 149.6M157.79M628.6M650.04M
High Estimate 155.48M162.7M645.36M689.39M
Year Ago Sales 140.77M--604.8M637.06M
Sales Growth (year/est) 9.00%--5.30%5.10%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. 0.540.750.620.57
EPS Actual 0.590.760.620.59
Difference 0.050.0100.02
Surprise % 9.30%1.30%0.00%3.50%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.560.82.773.09
7 Days Ago 0.560.82.773.09
30 Days Ago 0.560.812.773.09
60 Days Ago 0.650.82.93.2
90 Days Ago 0.650.82.93.2

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD USPHIndustrySectorS&P 500
Current Qtr. -5.10%----0.40%
Next Qtr. 5.30%----9.90%
Current Year 8.20%----4.30%
Next Year 11.60%----13.40%
Next 5 Years (per annum) 7.60%----11.09%
Past 5 Years (per annum) -1.10%------

Research Analysis

Analyst Price Targets

115.00
119.88 Average
103.39 Current
122.50 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains JP Morgan: Overweight to Overweight 3/13/2024
Maintains Barrington Research: Outperform to Outperform 3/1/2024
Maintains Barrington Research: Outperform to Outperform 1/3/2024
Maintains JP Morgan: Overweight to Overweight 11/17/2023
Maintains Barrington Research: Outperform to Outperform 11/9/2023
Initiated JP Morgan: Overweight 9/22/2023

Related Tickers